Expression of mutant ATXN2 in the SC produced a set of DEGs that was shared with previous transcriptome analyses of human ALS SC, TDP-43 mouse SC and SOD1 mouse SC and a set of DEGs that were altered by ATXN2 ASO therapy. Here, ATXN2 is linked to amyotrophic lateral sclerosis.